Direct regulation of TWIST by HIF-1α promotes metastasis
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
Stabilization of the hypoxia-inducible factor-1alpha (HIF-1alpha) transcription complex, caused by intratumoural hypoxia, promotes tumour progression and metastasis, leading to treatment failure and mortality in different types of human cancers. The transcription factor TWIST is a master regulator of gastrulation and mesoderm-specification and was implicated recently as an essential mediator of cancer metastasis. Notably, HIF-1alpha- and TWIST-null mice show similarities in their phenotypes. Here, we have shown that hypoxia or overexpression of HIF-1alpha promotes epithelial-mesenchymal transition (EMT) and metastastic phenotypes. We also found that HIF-1 regulates the expression of TWIST by binding directly to the hypoxia-response element (HRE) in the TWIST proximal promoter. However, siRNA-mediated repression of TWIST in HIF-1alpha-overexpressing or hypoxic cells reversed EMT and metastastic phenotypes. Co-expression of HIF-1alpha, TWIST and Snail in primary tumours of patients with head and neck cancers correlated with metastasis and the worst prognosis. These results provide evidence of a key signalling pathway involving HIF-1alpha and TWIST that promotes metastasis in response to intratumoural hypoxia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypoxia and HIFs contribute to EMT by upregulating transcriptional repressors such as SNAIL (Imai et al., 2003), TWIST (Yang et al., 2008), TCF3, ZFHX1A, and ZFHX1B (Krishnamachary et al., 2006), whose gene products in turn repress CDH1.”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Yang et al., 2008
In the citing paper
“Achieving vascular normalization, and thereby reducing tumour hypoxia and acidosis, is crucial because these stressors confer cancer cells with an invasive metastatic phenotype72”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [72]
In the citing paper
“Studies have demonstrated that HIF has a direct regulatory effect on EMT‐related proteins, such as zinc finger E‐box binding homeobox 1, Snail and Twist.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [85]
In the citing paper
“In experimental models, overexpression of HIF in tumor cells promotes metastasis”
From Hypoxic control of metastasis (2016) · cites this paper as [42]
In the citing paper
“Hypoxia or overexpression of HIF is sufficient to induce EMT and invasion in multiple cell types”
From Hypoxic control of metastasis (2016) · cites this paper as [42]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedEpithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“Intratumoural hypoxia, followed by stabilization and activation of the HIF-1α transcription complex, is one of the most important mechanisms that promotes metastasis and thereby, increases tumour aggressivenes”
BackgroundCancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247 · cited 1×
“dtd" [ ]> Tumour metastasis is the primary cause of death for most cancer patient”
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958 · cited 1×
“EMT, one of the central mechanisms that induces invasion and metastasis of tumours, is a process by which epithelial cells lose their polarity and are converted to a mesenchymal phenotyp”
BackgroundTwist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855 · cited 1×
“Recently, TWIST was shown to be essential in mediating cancer metastasi”
BackgroundCano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668 · cited 1×
“Snail is a zinc-finger transcriptional repressor shown to induce EMT through the repression of E-cadherin expression, one of the hallmarks of EM”
BackgroundSnail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121 · cited 1×
“Snail is a zinc-finger transcriptional repressor shown to induce EMT through the repression of E-cadherin expression, one of the hallmarks of EM”
BackgroundBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666 · cited 1×
“Snail is a zinc-finger transcriptional repressor shown to induce EMT through the repression of E-cadherin expression, one of the hallmarks of EM”
BackgroundCellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476 · cited 1×
“Mutant phenotypes of HIF-1α - and TWIST -null mice show similarities, including defects in somites and abnormal formation of neural fold”
Background
Cited by
Items 701–800 of 1,000
IDH2 reprograms mitochondrial dynamics in cancer through a HIF‐1α‐regulated pseudohypoxic state
Wang, Y., Agarwal, E., Bertolini, I., Ghosh, J. C., Seo, J. H., & Altieri, D. C. (2019) · The FASEB Journal · doi:10.1096/fj.201901366r · Cited by 35
HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer—Potential Targets for Anti-Tumor Therapy?
Gaete, D., Rodriguez, D., Watts, D., Sormendi, S., Chavakis, T., & Wielockx, B. (2021) · Cancers · doi:10.3390/cancers13050988 · Cited by 37
Zhang, F., Wang, X., Bai, Y., Hu, H., Yang, Y., Wang, J., Tang, Y., Ma, H., Feng, D., Li, D., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.670384 · Cited by 38
Role of glycosyltransferases in carcinogenesis; growth factor signaling and EMT/MET programs
Takahashi, M., Hasegawa, Y., Maeda, K., Kitano, M., & Taniguchi, N. (2022) · Glycoconjugate Journal · doi:10.1007/s10719-022-10041-3 · Cited by 35
Hypoxia‐inducible factor‐1α blocks differentiation of malignant gliomas
Lu, H., Li, Y., Shu, M., Tang, J., Huang, Y., Zhou, Y., Liang, Y., & Yan, G. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07441.x · Cited by 36
On translational regulation and EMT
Evdokimova, V. E., Tognon, C. E., & Sorensen, P. H. B. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.04.007 · Cited by 36
“These included messages ncoding well-known transcriptional inducers of EMT and metasasis, such as Snail1, Zeb2/Sip1, HIF1 , Lef-1 and TCF4, and other roteins that are involved in development and morphogenesis, ncluding Snail3, Scratch, Foxo3a, Prickle1, HMG20B, HoxC6 and oxC14, Atoh/Math1, LMO2, LIMD1, HOP, Mnt, Tob2,…”
BackgroundInfluentialXiong, H., Nie, X., 邹燕梅, Gong, C., Li, Y., Qiu, H., Qiu, H., Yang, L., Zhuang, L., Zhang, J., et al. (2017) · Journal of Cancer · doi:10.7150/jca.16607 · Cited by 35
Yang, H., Chang, C.-W., Vadivalagan, C., Pandey, S., Chen, S.-J., Lee, C.-C., Hseu, J., & Hseu, Y. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.93943 · Cited by 34
“HIF-1 α and Twist coexpression are linked to HNSCC metastasis and indicate a poor prognosis in patients [56].”
BackgroundChen, P., Tai, H., Lin, T., Wang, S., Lin, C., Chao, C., Yu, H., Tsai, Y., Lai, Y., Lin, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20171 · Cited by 35
Self-citationZhou, Y., Yu, M., Tie, C., Deng, Y., Wang, J., Yi, Y., Zhang, F., Huang, C., Zheng, H., Mei, L., et al. (2021) · Research · doi:10.34133/2021/9760398 · Cited by 34
Self-citationTwist Controls Skeletal Development and Dorsoventral Patterning by Regulating Runx2 in Zebrafish
Yang, D.-C., Tsai, C.-C., Liao, Y.-F., Fu, H.-C., Tsay, H.-J., Huang, T.-F., Chen, Y., & Hung, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027324 · Cited by 36
“Hypoxia downregulates type 1 and type 2 runx2b via the hif-1a-twist pathway It has been demonstrated that HIF-1a directly downregulated Twist under hypoxic conditions in mammalian cells [18].”
BackgroundBET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment
Andrieu, G. P., Shafran, J. S., Deeney, J. T., Bharadwaj, K. R., Rangarajan, A., & Denis, G. V. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.5ri0917-380rr · Cited by 35
Transcriptional regulation of FoxM1 by HIF‑1α mediates hypoxia‑induced EMT in prostate cancer
Tang, C., Liu, T., Wang, K., Wang, X., Xu, S., He, D., & Zeng, J. (2019) · Oncology Reports · doi:10.3892/or.2019.7248 · Cited by 40
Kim, S., Shim, S., Kwon, J., Ryoo, S., Byeon, J., Hong, J., Lee, J., Kwon, Y., Kim, J.-Y., & Kim, Y. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01237-8 · Cited by 36
RUFY3 interaction with FOXK1 promotes invasion and metastasis in colorectal cancer
Xie, R., Wang, J., Liu, X., Wu, L., Zhang, H., Tang, W., Li, X., Li, X., Peng, Y., Huang, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04011-1 · Cited by 32
Cochard, M., Ledoux, F., & Landkocz, Y. (2020) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2020.1816238 · Cited by 34
Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma
González-Martínez, S., Perez‐Mies, B., Pizarro, D., Caniego-Casas, T., Cortés, J., & Palacios, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147398 · Cited by 34
Yang, X., Wang, Y., Mao, T., Wang, Y., Liu, R., Yu, L., & Ding, J. (2021) · Biomaterials Science · doi:10.1039/d1bm01280k · Cited by 34
The Proto-Oncogene TWIST1 Is Regulated by MicroRNAs
Nairismägi, M., Füchtbauer, A. C., Labouriau, R., Bramsen, J. B., & Füchtbauer, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066070 · Cited by 34
Jian, H., Liu, B., & Zhang, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-1651-4 · Cited by 32
An, M. S., Yoo, J. H., Kim, K. H., Bae, K. B., Choi, C. S., Hwang, J. W., Kim, J. H., Kim, B. M., Kang, M. S., Oh, M. K., et al. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0488-7 · Cited by 32
“Intratumoral hypoxia might be an important factor in the activation of hypoxia-inducible factor-1, which can contribute in the acceleration of tumor metastasis [24].”
BackgroundNoncoding RNAs in Tumor Epithelial‐to‐Mesenchymal Transition
Lin, C.-W., Lin, P.-Y., & Yang, P. (2016) · Stem Cells International · doi:10.1155/2016/2732705 · Cited by 35
Wu, K. (2011) · PubMed · Cited by 37
Self-citationDükel, M., Streitfeld, W. S., Tang, T. C. C., Backman, L. R. F., Ai, L., May, W. S., & Brown, K. D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.730960 · Cited by 34
“TRIM29 Blocks TWIST1 Up-regulation during Hypoxic Response—Studies indicate that the oncogenic TWIST1 transcription factor is up-regulated in response to hypoxia (42), and our previous work documented that TRIM29 blocks TWIST1 activity and expression (27).”
BackgroundZhang, Q., Qin, Y., Zhao, J., Tang, Y., Hu, X. L., Zhong, W., Li, M., Zong, S., Li, M., Tao, H., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1282-6 · Cited by 34
Chen, H., & Wu, K. (2015) · Stem Cells International · doi:10.1155/2016/6439864 · Cited by 35
Self-citationZhang, J., Ma, X., & Fan, D. (2021) · Foods · doi:10.3390/foods10061195 · Cited by 33
“HIF-1α stimulates EMT in tumors by regulating EMT-related signaling pathways (TGF-β, Notch, and Wnt/β-catenin signaling pathways) [13–15], modulating EMT-TF expression [16,17] and EMT-associated miRNA and lncRNA networks [18].”
BackgroundRole of heparan sulfatases in ovarian and breast cancer.
Khurana, A., Beleford, D. T., He, X., CHIEN, J. R., & Shridhar, V. (2013) · Europe PMC (PubMed Central) · Cited by 32
Chen, Y., Li, X., Wu, S., Xu, G., Zhou, Y., Gong, L., Li, Z., & Yang, D. (2014) · Medical Oncology · doi:10.1007/s12032-014-0304-1 · Cited by 31
Schwock, J., Bradley, G., Ho, J., Perez‐Ordoñez, B., Hedley, D. W., Irish, J. C., & Geddie, W. R. (2010) · BMC Clinical Pathology · doi:10.1186/1472-6890-10-1 · Cited by 31
Zhou, C., Liu, J., Tang, Y., Zhu, G., Zheng, M. H., Jiang, J. D., Yang, J., & Liang, X. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01114.x · Cited by 33
Pharmacological HIF-inhibition attenuates postoperative adhesion formation
Strowitzki, M. J., Ritter, A. S., Radhakrishnan, P., Harnoss, J. M., Opitz, V. M., Biller, M., Wehrmann, J., Keppler, U., Scheer, J., Wallwiener, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13638-z · Cited by 30
Linder, A., Thulin, M. H., Damber, J., & Welén, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-35332-4 · Cited by 34
EMT signaling: potential contribution of CRISPR/Cas gene editing
Mohammadinejad, R., Biagioni, A., Arunkumar, G., Shapiro, R. S., Chang, K., Sedeeq, M., Taiyab, A., Hashemabadi, M., Pardakhty, A., Mandegary, A., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03449-3 · Cited by 32
Hypoxia suppresses myofibroblast differentiation by changing RhoA activity
Leinhos, L., Peters, J., Krull, S., Helbig, L., Vogler, M., Levay, M., van Belle, G. J., Ridley, A. J., Lutz, S., Katschinski, D. M., et al. (2019) · Journal of Cell Science · doi:10.1242/jcs.223230 · Cited by 30
“Jo u rn al o f Ce ll Sc ie n ce other important steps in the remodeling phase of wound healing including innate immune function and epithelial-mesenchymal transition (EMT) (Scheid et al., 2002; Wottawa et al., 2013; Yang et al., 2008).”
BackgroundHypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment
Capatina, A. L., Malcolm, J. R., Stenning, J., Moore, R. L., Bridge, K. S., Brackenbury, W. J., & Holding, A. N. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1421629 · Cited by 35
Dai, M., Chen, N., Li, J., Tan, L., Li, X., Wen, J., Lei, L.-S., & Guo, D. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153580 · Cited by 32
Regulatory roles of RNA modifications in breast cancer
Kumari, K., Groza, P., & Aguiló, F. (2021) · NAR Cancer · doi:10.1093/narcan/zcab036 · Cited by 31
“Hypoxic environments, through the action of hypoxiainducible factors (HIF), have been linked with EMT and thus with acquisition of stem cell-like properties that favor migration and invasion in breast cancer (67,68).”
Travelling under pressure - hypoxia and shear stress in the metastatic journey
Ildız, E. S., Gvozdenovic, A., Kovacs, W. J., & Aceto, N. (2023) · Clinical & Experimental Metastasis · doi:10.1007/s10585-023-10224-8 · Cited by 39
Identification of Targets of Twist1 Transcription Factor in Thyroid Cancer Cells
Maro, G. D., Orlandella, F. M., Bencivenga, T. C., Salerno, P., Ugolini, C., Basolo, F., Maestro, R., & Salvatore, G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3799 · Cited by 31
“Of note, Twist1 is a downstream target of hypoxia-inducible factor 1 (31).”
BackgroundFernández‐Barral, A., Orgaz, J. L., Gómez, V., del Peso, L., Calzada, M. J., & Jiménez, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032989 · Cited by 31
Liu, N., WANG, Y., Zhou, Y., Pang, H., Zhou, J., QIAN, P., Liu, L., & Zhang, H. (2014) · Oncology Reports · doi:10.3892/or.2014.3495 · Cited by 33
“The continuous proliferation of tumor cells results in the center portion of hypoxia, which greatly promotes EMT (10,11).”
BackgroundNiu, W., Zhang, M., Chen, H., Wang, C., Shi, N., Jing, X., Ge, L., Chen, T., & Tang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9705 · Cited by 31
Metabolic hijacking: A survival strategy cancer cells exploit?
Mitchell, M. I., & Engelbrecht, A. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.11.010 · Cited by 31
Zhu, G., Peng, F., Gong, W. J., She, L., Wei, M., Tan, H., Chen, C., Zhang, D., Guo, L., Huang, D., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5949 · Cited by 32
“There are two possible mechanisms: HIF-1α may activate the EMT transcription factor Twist in hypoxic HNSCC cells (34), or MTDH may mediate the epigenetic regulation of Twist in cancer cells (35).”
BackgroundGDF15 promotes epithelial-to-mesenchymal transition in colorectal
Zhang, Y., Wang, X., Zhang, M., Zhang, Z., Jiang, L., & Li, L. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1466146 · Cited by 30
Liu, Y., Meng, F., Wang, J., Liu, M., Yang, G., Song, R., Zheng, T., Liang, Y., Zhang, S., Yin, D., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4113 · Cited by 31
CTCF Expression and Dynamic Motif Accessibility Modulates Epithelial–Mesenchymal Gene Expression
Johnson, K. S., Hussein, S., Chakraborty, P., Muruganantham, A., Mikhail, S., Gonzalez, G., Song, S., Jolly, M. K., Toneff, M. J., Benton, M. L., et al. (2022) · Cancers · doi:10.3390/cancers14010209 · Cited by 30
Jia, J.-B., Wang, W., Sun, H., Liu, L., Zhu, X., Kong, L., Chai, Z., Zhang, W., Zhang, J., Xu, H., et al. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9435-1 · Cited by 31
“There were close relationships among irradiation and hypoxia/HIF-1α [39], hypoxia/HIF-1α and EMT [41, 42 ], and TMPRSS4 and EMT [37].”
BackgroundRufy3 promotes metastasis through epithelial–mesenchymal transition in colorectal cancer
Xie, R., Wang, J., Tang, W., Li, Y., Peng, Y., Zhang, H., Liu, G., Huang, X., Zhao, J., Li, A., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.001 · Cited by 30
Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunities
Shen, M., & Kang, Y. (2020) · Genes & Development · doi:10.1101/gad.343251.120 · Cited by 34
Xu, W., Kwon, J.-H., Moon, Y. H., Kim, Y. B., Yu, Y. S., Lee, N., Choi, K. Y., Kim, Y. S., Park, Y. K., Kim, B. W., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1713-4 · Cited by 29
Vig, N., Mackenzie, I. C., & Biddle, A. (2015) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12306 · Cited by 30
“This promotes EMT and metastasis of oral SCC, and expression of HIF1a or Twist in primary human tumours can be correlated with metastasis and poor prognosis (44, 50).”
BackgroundHead and neck squamous cell carcinoma
(2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00233-2 · Cited by 31
Liu, T., Zhao, L., Hou, H., Ding, L., Chen, W., & Li, X. (2017) · Tumor Biology · doi:10.1177/1010428317692225 · Cited by 31
Bommi, P. V., Ravindran, S., Raychaudhuri, P., & Bagchi, S. (2018) · Oncotarget · doi:10.18632/oncotarget.26168 · Cited by 32
Downregulation of miR-1 enhances tumorigenicity and invasiveness in oral squamous cell carcinomas
Peng, C., Liao, Y., Lu, M., Yu, C., Yu, C., & Chou, M. (2017) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.12.003 · Cited by 29
Tumor microenvironment – Unknown niche with powerful therapeutic potential
Kolenda, T., Przybyła, W., Kapałczyńska, M., Teresiak, A., Zajączkowska, M. M., Bliźniak, R., & Lamperska, K. M. (2018) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2018.01.004 · Cited by 33
Malm, S. W., Amouzougan, E. A., & Klimecki, W. T. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.04.008 · Cited by 35
“NonTGFβ receptor-mediated activators of EMT have also been described, including receptor tyrosine kinases, the Wnt, Notch, and Hedgehog signaling pathways, the inflammatory cytokine IL-6, and hypoxia through HIF-α signaling (Briscoe and Thérond, 2013; Li et al., 2006; Luo et al., 2011; Niehrs, 2012; Sullivan et al., 2…”
BackgroundZheng, Y., Wang, Z., Xiong, X., Zhong, Y., Zhang, W., Dong, Y., Li, J., Zhu, Z., Zhang, W., Wu, H., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27022 · Cited by 30
“During malignant progression, it has been proposed that carcinoma cells undergo an EMT, in which they lose epithelial characteristics and acquire invasive properties (Katafiasz, Smith, & Wahl, 2011; Thiery, Acloque, Huang, & Nieto, 2009; Yang et al., 2008).”
BackgroundAndo, A., Hashimoto, N., Sakamoto, K., Omote, N., Miyazaki, S., Nakahara, Y., Imaizumi, K., Kawabe, T., & Hasegawa, Y. (2019) · Cancer Science · doi:10.1111/cas.14027 · Cited by 31
Inhibition of Heat Shock Protein 90 suppresses TWIST1 Transcription
Chong, K. Y., Kang, M., Garofalo, F., Ueno, D., Liang, H., Cady, S. L., Madarikan, O., Pitruzzello, N., Tsai, C.-H., Hartwich, T. M. P., et al. (2019) · Molecular Pharmacology · doi:10.1124/mol.119.116137 · Cited by 32
“…proteins that have been reported to regulate TWIST1 transcription in human cells, namely, b-catenin, HIF-1a, HIF-1b, STAT3, STAT5, STAT6, N-Myc, and MyoD1 (Howe et al., 2003; Cheng et al., 2008; Yang et al., 2008; Koutalianos et al., 2015; Selmi et al., 2015; Zhao et al., 2017; Chen et al., 2018).”
BackgroundZhang, K.-D., Hu, B., Cen, G., Yang, Y., Chen, W., Guo, Z., Wang, X., Zhao, Q., & Qiu, Z. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i19.2349 · Cited by 29
Huang, W., Zhang, J., Huo, M., Gao, J., Yang, T., Yin, X., Wang, P., Leng, S., Feng, D., Chen, Y., et al. (2021) · Advanced Science · doi:10.1002/advs.202001515 · Cited by 37
Dynamics of epithelial–mesenchymal plasticity driving cancer drug resistance
Bangarh, R., Saini, R. V., Saini, A. K., Singh, T., Joshi, H., Ramniwas, S., Shahwan, M. J., & Tuli, H. S. (2024) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.07.002 · Cited by 27
Iwasaki, K., Ninomiya, R., Shin, T., Nomura, T., Kajiwara, T., Hijiya, N., Moriyama, M., Mimata, H., & Hamada, F. (2018) · Cancer Science · doi:10.1111/cas.13754 · Cited by 30
Vitamin C: A stem cell promoter in cancer metastasis and immunotherapy
Fu, J., Wu, Z., Liu, J., & Wu, T. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110588 · Cited by 32
Targeting Histone Modifications in Bone and Lung Metastatic Cancers
Edwards, C. M., & Johnson, R. W. (2021) · Current Osteoporosis Reports · doi:10.1007/s11914-021-00670-2 · Cited by 35
Aoyagi, K., Minashi, K., Igaki, H., Tachimori, Y., Nishimura, T., Hokamura, N., Ashida, A., Daiko, H., Ochiai, A., Muto, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018196 · Cited by 30
Nemenoff, R. A., Weiser‐Evans, M. C. M., & Winn, R. A. (2008) · PPAR Research · doi:10.1155/2008/156875 · Cited by 28
“Both Snail and Twist appear to play critical roles in breast cancer metastasis [60, 61].”
BackgroundRegulation of Inflammation-Mediated Chronic Diseases by Botanicals
Sung, B., Prasad, S., Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2012) · Advances in botanical research · doi:10.1016/b978-0-12-394591-4.00003-9 · Cited by 33
Phosphorylation of basic helix–loop–helix transcription factor Twist in development and disease
Xue, G., & Hemmings, B. A. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110678 · Cited by 28
Li, H., Yao, Z., He, W., Gao, H., Bai, Y., Yang, S., Zhang, L., Zhan, R., Tan, J., Zhou, J., et al. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0421-1 · Cited by 33
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
Li, A. G., Murphy, E. C., Culhane, A. C., Powell, E., Wang, H., Bronson, R. T., Von, T., Giobbie‐Hurder, A., Gelman, R. S., Briggs, K. J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807112115 · Cited by 29
“HIF-1 α has also been implicated in still other events associated with tumor progression, e.g., the activation of EMT-inducing transcription factors such as SNAI1 and TWIST1 (38, 54).”
High-throughput mechanotransduction in Drosophila embryos with mesofluidics
Shorr, A. Z., Sönmez, U. M., Minden, J. S., & LeDuc, P. R. (2019) · Lab on a Chip · doi:10.1039/c8lc01055b · Cited by 28
Liao, T., Chen, Y.-H., Li, Z.-Y., Hsiao, A.-C., Huang, Y.-L., Hao, R.-X., Tai, S., Chu, P., Shih, J.-W., Kung, H., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0622 · Cited by 29
Self-citationZhang, Y., Xie, Y., Xia, S., Ge, X., Li, J., Liu, F., Jia, F., Wang, S., Zhou, Q., Gao, M., et al. (2025) · Advanced Science · doi:10.1002/advs.202411980 · Cited by 36
Wegwitz, F., Kluth, M.-A., Maenz, C., Otto, B., Gruner, K., Heinlein, C., Kühl, M., Warnecke, G., Schumacher, U., Deppert, W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012103 · Cited by 27
Zerbib, E., Arif, T., Shteinfer‐Kuzmine, A., Caspi, V. C., & Shoshan‐Barmatz, V. (2021) · Cancers · doi:10.3390/cancers13112850 · Cited by 27
Soheilifar, M. H., Masoudi-Khoram, N., Madadi, S., Nobari, S., Maadi, H., Neghab, H. K., Amini, R., & Pishnamazi, M. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.06.019 · Cited by 28
Sakamoto, K., Hashimoto, N., Kondoh, Y., Imaizumi, K., Aoyama, D., Kohnoh, T., Kusunose, M., Kimura, M., Kawabe, T., Taniguchi, H., et al. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00061.2012 · Cited by 29
Xiong, Z., Guo, M., Yu, Y., Zhang, F., Ge, M.-K., Chen, G., & Shen, S.-M. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw089 · Cited by 29
“Unlike other EMT-associated HIF-1 target genes, such as Twist and Snail (17,18,20), which at Periodicals D ept U niversity L ibraries N orthern Illinois U niversity on A ugust 26, 2016 http://carcin.oxfordjournals.org/ D ow nloaded from Ac ce pt ed M an us cr ipt directly induces the EMT program by transcriptionally i…”
BackgroundInfluentialMartin, A. R., Ronco, C., Demange, L., & Benhida, R. (2017) · MedChemComm · doi:10.1039/c6md00432f · Cited by 31
Zhu, S., Deng, S.-J., He, C., Liu, M., Chen, H., Zeng, Z., Zhong, J., Zeng, Y., Deng, S., Wu, H., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5089 · Cited by 31
“HIF-1α induces the expression of TWIST, which is the master transcription factor in EMT, by binding directly to the hypoxia response element (HRE) in the TWIST1 proximal promoter [9].”
BackgroundNobiletin inhibits hypoxia‐induced epithelial‐mesenchymal transition in renal cell carcinoma cells
Liu, F., Zhang, S., Yin, M., Guo, L., Xu, M., & Wang, Y. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27511 · Cited by 27
Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer
Beck, T. N., Chikwem, A. J., Solanki-Patel, N., & Golemis, E. A. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00062.2014 · Cited by 29
Wang, J., Yan, F., Wang, L., Yin, W., Chang, T., Liu, J., & Wu, K. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22802 · Cited by 27
Self-citationThe Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem Cells
Jahangiri, L., Ishola, T., Pucci, P., Trigg, R. M., Pereira, J. D., Williams, J. A., Cavanagh, M. L., Gkoutos, G. V., Tsaprouni, L., & Turner, S. D. (2021) · Cancers · doi:10.3390/cancers13061239 · Cited by 29
Dynamic regulation of O-GlcNAcylation and phosphorylation on STAT3 under hypoxia-induced EMT
Fu, Y., Ning, L., Feng, J., Yu, X., Guan, F., & Li, X. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110277 · Cited by 27
Zeng, Y., Zhan, Y., Liu, X., Ma, J., Liu, H., Li, H., Yi, T., Zhu, Q., Du, G., Zhao, L., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.137724 · Cited by 28
TWIST1 promoter methylation is associated with prognosis in tonsillar squamous cell carcinoma
Kwon, M. J., Kwon, J. H., Nam, E. S., Shin, H. S., Lee, D. J., Kim, J. H., Rho, Y. S., Sung, C. O., Lee, W. J., & Cho, S. J. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.03.004 · Cited by 26
“One plausible explanation is that HIF-1 regulates the TWIST expression by binding directly to the hypoxia-response element in the TWIST proximal promoter, which is a common feature in solid cancers [25,26].”
BackgroundWu, C., Gupta, N., Huang, Y.-H., Zhang, H., Alshareef, A., Chow, A., & Lai, R. L. (2018) · BMC Cancer · doi:10.1186/s12885-018-4300-2 · Cited by 30
“Hypoxia-inducible factors (HIFs), which exists in specific tumor microenvironment niche, is also known to promote metastasis, tumorigenicity and CSC-like features in certain human cancer models [24, 25].”
Epithelial–Mesenchymal Transition in Development and Diseases
Wu, Y., & Zhou, B. P. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6615-5_9 · Cited by 25
Todd, V. M., Vecchi, L. A., Clements, M. E., Snow, K. P., Ontko, C. D., Himmel, L. E., Pinelli, C. J., Rafat, M., & Johnson, R. W. (2021) · Communications Biology · doi:10.1038/s42003-021-02648-3 · Cited by 29
Maru, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-1757-7_11 · Cited by 25
Potential molecular mechanisms and clinical progress in liver metastasis of breast cancer
Liu, H., Li, X., Li, H., Feng, L., Sun, G., Sun, G., Wu, L., Hu, Y. H., Liu, L., & Wang, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112824 · Cited by 28
Regulating the Expression of HIF-1α or lncRNA: Potential Directions for Cancer Therapy
Zhang, M., Zhang, Y., Ding, Y., Huang, J., Yao, J., Xie, Z., Lv, Y., & Zuo, J. (2022) · Cells · doi:10.3390/cells11182811 · Cited by 30
Luo, Y., CUI, X., Zhao, J., HAN, Y., Li, M., Lin, Y., Jiang, Y., & Lan, L. (2013) · Oncology Reports · doi:10.3892/or.2013.2905 · Cited by 25
“Previous studies have verified that EMT is one of the crucial processes through which cancer cells migrate from the primary microenvironment to distant sites (2,3).”
BackgroundGSK-3β-dependent downregulation of γ-taxilin and αNAC merge to regulate ER stress responses
Hotokezaka, Y., Katayama, I., van Leyen, K., & Nakamura, T. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.90 · Cited by 27
Walk, E. L., & Weed, S. A. (2011) · Cancers · doi:10.3390/cancers3010747 · Cited by 26
Metadata
- Authors
- Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J.
- Affiliations
- National Yang Ming University (TW)
- Taipei Veterans General Hospital (TW)
- Mackay Memorial Hospital (TW)
- National Taiwan University (TW)
- Corresponding author
- Wu, Kou-Juey
- Venue
- Nature Cell Biology
- Published
- 2008-02-24
- Volume
- 10
- Issue
- 3
- Pages
- 295-305
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2134361367
- Cited by
- 1,345
- References
- 41
- Citations by year
- 2026: 24 · 2025: 46 · 2024: 62 · 2023: 63 · 2022: 73 · 2021: 104 · 2020: 74 · 2019: 66 · 2018: 82 · 2017: 80 · 2016: 96 · 2015: 82 · 2014: 89 · 2013: 94 · 2012: 76
- FWCI
- 26.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- HIF-1α, Twist, metastasis, epithelial-mesenchymal transition, hypoxia response element, transcriptional regulation, snails, head and neck cancer, tumor progression
- MeSH terms
- Snail Family Transcription Factors, Cell Communication, Cell Differentiation, Humans, Neoplasm Metastasis, Neoplasms, Nuclear Proteins, Phenotype, Prognosis, Transcription Factors, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, Hypoxia-Inducible Factor 1, alpha Subunit, Twist-Related Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.